A research team was looking to make a new anti-inflammatory medication when they found some incredible side effects ...

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after ...

The ADDF’s CFO discusses the areas that foundation is raising money for and how its reacting to the current economic ...

If Island Pharma’s drug keeps delivering, it could fast-track approval. And in a world with millions of dengue cases a year, ...

NKGen Biotech has activated two new trial sites in Canada and Florida, US, for the Phase I/IIa study of its cryopreserved expanded autologous natural killer (NK) cell therapy, troculeucel, in patients ...

CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...

Bayer and Tsinghua University (THU) announced that they have extended their research collaboration of 16 years by an additional three years, to further accelerate the translation of scientific ...

AI-driven healthcare innovations are reshaping cancer research and boosting investment opportunities. Read more insights on ...

“ATR-258, a synthetic small molecule, has favourable pharmacokinetics and in Phase 1 clinical trials has been administered just once a day as a capsule, making it a straightforward, patient-friendly ...

GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with ...

The Beat AML Master Trial found high remission rates and promising safety with triplet therapy in patients with acute myeloid leukemia (AML), according to Ashley Yocum, PhD.